Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
|
0 |
|
|
|
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
|
0 |
|
|
|
LYMPHOMA, SOMATIC
|
disease |
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
PROSTATE CANCER, SOMATIC
|
disease |
|
Neoplastic Process
|
6
|
18
|
0.100 |
None |
|
0 |
1
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.310 |
None |
1.000 |
1 |
|
2001 |
2001 |
Juvenile-Onset Still Disease
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
171
|
41
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
PROSTATE CANCER, HEREDITARY, 1
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
62
|
2
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Prostate cancer, familial
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
116
|
25
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
450
|
128
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
131
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Juvenile psoriatic arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
138
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
131
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Longevity
|
phenotype |
|
Temporal Concept
|
48
|
74
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
5
|
2018 |
2018 |
Adverse effects, not elsewhere classified
|
disease |
|
Injury or Poisoning
|
55
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Testicular Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
124
|
31
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Schizoaffective Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
126
|
61
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Age at menarche
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
267
|
591
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |